News for CanBas Co., Ltd. (4575.T)

Published at

Apr 9, 2024 7:00 PM

by globenewswire.com

mixed

mixed

TROP-2 Inhibitors Market to Boost by 2034, Predicts DelveInsight | Key Companies to Look Out - Daiichi Sankyo, AstraZeneca, Kelun Biotech, Merck, DualityBio, BioNTech, BiOneCure Therapeutics

According to DelveInsight’s analysis, the growth of the TROP-2 Inhibitors market is expected to be mainly driven by increasing incidence, a rise in...

GILDD.BA TCON INCY I1NC34.SA 0J9P.L 4575.T

Read more →
Published at

Jul 10, 2023 11:01 PM

by prnewswire.com

mixed

mixed

KRAS Inhibitors Market is Evolving Rapidly at a CAGR of 36% by 2032, Assesses DelveInsight

/PRNewswire/ -- DelveInsight's KRAS Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, emerging KRAS...

TCON INCY I1NC34.SA 0J9P.L 4575.T

Read more →
Published at

May 10, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Checkpoint Inhibitors Clinical Trial Pipeline Appears Robust with 180+ Key Pharma Players Actively Working in the Space, Estimates DelveInsight

The prevalence of cancer has been rising over the past few years, which prompts the growing demand for treatment options. The introduction of immune...

EXEL EX9.DE ENLV.TA ENLV BRM.DE BMYB34.SA BMY.MX BMY.BA BMY 2696.HK 0IJO.L TCON SGEN OPHLY OPHLF INCY I1NC34.SA ASCLF 4528.T 1672.HK 0J9P.L 0A8R.L 4575.T

Read more →
Published at

May 1, 2023 7:00 PM

by globenewswire.com

mixed

mixed

DelveInsight Evaluates a Robust Antibody-drug Conjugates in Oncology Clinical Trial Pipeline as 30+ Influential Pharma Players to Set Foot in the 7MM

The introduction of ADCs into the market and the promising clinical results of more ADC prospects have increased industry interest in ADCs as a treatment...

LLY.MX LLY.DE LLY.BA LLY LILY34.SA 4575.T 2696.HK 0Q1G.L TCON SGEN OPHLY OPHLF INCY I1NC34.SA GILDD.BA CMVLF CLLS ASCLF ALCLS.PA 4528.T 1672.HK 0J9P.L 0A8R.L SRNE 0L85.L

Read more →
Published at

Jan 2, 2023 4:30 PM

by prnewswire.com

mixed

mixed

Propulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain | DelveInsight

/PRNewswire/ -- DelveInsight's 'Pancreatic Cancer Pipeline Insight – 2022' report provides comprehensive global coverage of available, marketed, and pipeline...

INNMF ATX.AX XBIT PBLA INCY I1NC34.SA GRTX BNTXN.MX BNTX BLRX.TA BLRX 600276.SS 0J9P.L 0A3M.L TRVXO.OL TRVX.OL SGEN RCUS QLGN NUVB-WT NUVB MRUS LLY.MX LLY.DE LLY.BA LLY LILY34.SA IBRX AGEN 9995.HK 4575.T 0RIS.L 0Q1G.L 0A8R.L

Read more →